ELIZABETH SHPALL to Thrombocytopenia
This is a "connection" page, showing publications ELIZABETH SHPALL has written about Thrombocytopenia.
Connection Strength
0.789
-
Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia. Front Immunol. 2022; 13:1018047.
Score: 0.570
-
Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Transplant Cell Ther. 2021 05; 27(5):430.e1-430.e7.
Score: 0.127
-
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment. Biol Blood Marrow Transplant. 2007 Apr; 13(4):469-77.
Score: 0.048
-
Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractions. Prog Clin Biol Res. 1994; 389:415-20.
Score: 0.019
-
Intensive single-agent mitoxantrone for metastatic breast cancer. J Natl Cancer Inst. 1988 Apr 06; 80(3):204-8.
Score: 0.013
-
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood. 2006 Apr 15; 107(8):3074-80.
Score: 0.011